Literature DB >> 12749848

Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway.

I A McNeish1, S Bell, T McKay, T Tenev, M Marani, N R Lemoine.   

Abstract

We have constructed Ad CMV-Smac, a recombinant adenovirus encoding Smac/DIABLO, the recently described second mitochondrial activator of caspases. Transfection of ovarian carcinoma cells with Ad CMV-Smac at multiplicities of infection of 3-60 pfu/cell leads to increasing apoptosis in a dose-dependent manner. Western blot analysis confirms that Smac-induced apoptosis proceeds via a pathway mediated primarily by caspase-9 that can be inhibited by zLEHD-fmk and overexpression of the X-linked inhibitor of apoptosis protein (XIAP). In contrast, there is no cleavage of either caspase-8 or caspase-12. Ad CMV-Smac appears to induce apoptosis independently of cytochrome c release from mitochondria and is not inhibited by overexpression of Bcl-2. Ad CMV-Smac can combine with other proapoptotic factors, such as cisplatin, paclitaxel, and procaspase-3, to produce greater levels of apoptosis in transfected cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12749848     DOI: 10.1016/s0014-4827(03)00073-9

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  22 in total

1.  Gene transfer: Bax to the future for cancer therapy.

Authors:  N R Lemoine; I A McNeish
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

2.  AD-O53.2--a novel recombinant fusion protein combining the activities of TRAIL/Apo2L and Smac/Diablo, overcomes resistance of human cancer cells to TRAIL/Apo2L.

Authors:  Jerzy S Pieczykolan; Konrad Kubiński; Maciej Masłyk; Sebastian D Pawlak; Anna Pieczykolan; Piotr K Rózga; Michał Szymanik; Marlena Gałązka; Małgorzata Teska-Kamińska; Bartłomiej Żerek; Katarzyna Bukato; Katarzyna Poleszak; Albert Jaworski; Wojciech Strożek; Robert Świder; Rafał Zieliński
Journal:  Invest New Drugs       Date:  2014-09-04       Impact factor: 3.850

3.  [Apoptotic effect of coix polysaccharides on A549 lung cancer cells in vitro].

Authors:  Xiangyi Lu; Wei Liu; Cheng Luo
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-11

4.  Cytotoxicity, DNA damage, and apoptosis induced by titanium dioxide nanoparticles in human non-small cell lung cancer A549 cells.

Authors:  Yurong Wang; Haiyan Cui; Jiaping Zhou; Fengjuan Li; Jinju Wang; Mianhua Chen; Qingdai Liu
Journal:  Environ Sci Pollut Res Int       Date:  2014-10-24       Impact factor: 4.223

5.  Stable transfection of extrinsic Smac gene enhances apoptosis-inducing effects of chemotherapeutic drugs on gastric cancer cells.

Authors:  Li-Duan Zheng; Qiang-Song Tong; Liang Wang; Jun Liu; Wei Qian
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

6.  Effect of Smac on TRAIL-induced apoptosis of prostate cancer cell line PC-3 and the molecular mechanism.

Authors:  Miao Wang; Tao Huang; Fuqing Zeng; Guosong Jiang; Liang Wang; Liduan Zheng; Qiangsong Tong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-04-20

Review 7.  Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  J Cell Biochem       Date:  2008-07-01       Impact factor: 4.429

8.  Apoptosis induction in BEFV-infected Vero and MDBK cells through Src-dependent JNK activation regulates caspase-3 and mitochondria pathways.

Authors:  Chun-Yen Chen; Chin-Yang Chang; Hung-Jen Liu; Ming-Huei Liao; Chi-I Chang; Jue-Liang Hsu; Wen-Ling Shih
Journal:  Vet Res       Date:  2009-10-23       Impact factor: 3.683

9.  Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer.

Authors:  S K Baird; J L Aerts; A Eddaoudi; M Lockley; N R Lemoine; I A McNeish
Journal:  Oncogene       Date:  2007-12-10       Impact factor: 9.867

10.  Coupling of caspase-9 to Apaf1 in response to loss of pRb or cytotoxic drugs is cell-type-specific.

Authors:  Andrew T Ho; Qin H Li; Razqallah Hakem; Tak W Mak; Eldad Zacksenhaus
Journal:  EMBO J       Date:  2004-01-08       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.